Literature DB >> 3509288

Kinetics of drug action in disease states. XXII. Effects of contraceptive steroids on the pharmacodynamics of ethanol in rats.

S Wanwimolruk1, G Levy.   

Abstract

This investigation was designed to determine the effect of treatment with contraceptive steroids on the central nervous system depressant activity of ethanol. Adult female rats received oral doses of ethynyl estradiol (0.1 mg kg-1 day-1), ethynyl estradiol and norethindrone (0.1 and 10 mg kg-1 day-1), or vehicle only for 14 days. Ethanol was then infused slowly iv until the animals lost their righting reflex. The concentrations of ethanol at that time in serum and cerebrospinal fluid were statistically significantly higher in rats treated with the estrogen-progestin combination than in control animals. Ethanol concentrations in rats treated only with the estrogen were intermediate and did not differ significantly from control values. These results indicate that treatment with an estrogen-progestin combination is associated with a decreased sensitivity of the central nervous system to the hypnotic activity of ethanol. This evidence of a pharmacodynamic interaction between contraceptive steroids and ethanol in rats is consistent with a recent clinical report of significant contraceptive steroid-related improvement in tolerance to ethanol with no apparent effect on the pharmacokinetics of ethanol.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509288     DOI: 10.1023/a:1016412312871

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Alcohol effects in women during the menstrual cycle.

Authors:  B M Jones; M K Jones
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  The effectof norethynodrel, norethindrone and ethynodiol diacetate on hepatic microsomal drug metabolism.

Authors:  R I Freudenthal; E Amerson; J Martin; M E Wall
Journal:  Pharmacol Res Commun       Date:  1974-10

3.  Effect of phenobarbital on the ethynyl estradiol-induced cholestasis in the rat.

Authors:  J J Gumucio; L Accatino; A M Macho; A Contreras
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

4.  Modulation by estradiol of serotonin receptors in brain.

Authors:  A Biegon; B S McEwen
Journal:  J Neurosci       Date:  1982-02       Impact factor: 6.167

5.  Impairment of antipyrine metabolism by low-dose oral contraceptive steroids.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

6.  Pharmacodynamic evaluation of the benzodiazepine-oral contraceptive interaction.

Authors:  P D Kroboth; R B Smith; G P Stoehr; R P Juhl
Journal:  Clin Pharmacol Ther       Date:  1985-11       Impact factor: 6.875

7.  Influence of sex and oral contraceptive steroids on paracetamol metabolism.

Authors:  J O Miners; J Attwood; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

8.  The effects of oestrogens and progestins on the response of mice to barbiturates.

Authors:  A Blackham; P S Spencer
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

9.  Kinetics of drug action in disease states XII: Effect of experimental liver diseases on the pharmacodynamics of phenobarbital and ethanol in rats.

Authors:  M Danhof; M Hisaoka; G Levy
Journal:  J Pharm Sci       Date:  1985-03       Impact factor: 3.534

10.  Combined toxic effects of tetracycline and ethinyl estradiol on liver function of mice.

Authors:  R Böcker; C J Estler; C Feiner; G Hopf; K Schrader; W Schramm
Journal:  Res Exp Med (Berl)       Date:  1985
View more
  2 in total

1.  Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models.

Authors:  Meindert Danhof
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-30       Impact factor: 2.745

Review 2.  Gender differences in moderate drinking effects.

Authors:  M S Mumenthaler; J L Taylor; R O'Hara; J A Yesavage
Journal:  Alcohol Res Health       Date:  1999
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.